474 related articles for article (PubMed ID: 33636128)
1. Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis.
Heyde A; Rohde D; McAlpine CS; Zhang S; Hoyer FF; Gerold JM; Cheek D; Iwamoto Y; Schloss MJ; Vandoorne K; Iborra-Egea O; Muñoz-Guijosa C; Bayes-Genis A; Reiter JG; Craig M; Swirski FK; Nahrendorf M; Nowak MA; Naxerova K
Cell; 2021 Mar; 184(5):1348-1361.e22. PubMed ID: 33636128
[TBL] [Abstract][Full Text] [Related]
2. Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells.
Kandarakov O; Belyavsky A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114351
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis - Beyond Conventional Cardiovascular Risk Factors.
Zuriaga MA; Fuster JJ
Circ J; 2023 Feb; 87(3):394-400. PubMed ID: 34433749
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
Amorós-Pérez M; Fuster JJ
Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
[TBL] [Abstract][Full Text] [Related]
5. Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction.
Wang Y; Sano S; Yura Y; Ke Z; Sano M; Oshima K; Ogawa H; Horitani K; Min KD; Miura-Yura E; Kour A; Evans MA; Zuriaga MA; Hirschi KK; Fuster JJ; Pietras EM; Walsh K
JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32154790
[TBL] [Abstract][Full Text] [Related]
6. Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis.
Natarajan P; Jaiswal S; Kathiresan S
Circ Genom Precis Med; 2018 Jul; 11(7):e001926. PubMed ID: 29987111
[TBL] [Abstract][Full Text] [Related]
7. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
Fuster JJ; MacLauchlan S; Zuriaga MA; Polackal MN; Ostriker AC; Chakraborty R; Wu CL; Sano S; Muralidharan S; Rius C; Vuong J; Jacob S; Muralidhar V; Robertson AA; Cooper MA; Andrés V; Hirschi KK; Martin KA; Walsh K
Science; 2017 Feb; 355(6327):842-847. PubMed ID: 28104796
[TBL] [Abstract][Full Text] [Related]
8. Clinical consequences of clonal hematopoiesis of indeterminate potential.
Steensma DP
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F.
Misaka T; Kimishima Y; Yokokawa T; Ikeda K; Takeishi Y
J Cardiol; 2023 Jan; 81(1):3-9. PubMed ID: 35165011
[TBL] [Abstract][Full Text] [Related]
10. Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis.
Polizio AH; Park E; Walsh K
Curr Atheroscler Rep; 2023 Mar; 25(3):105-111. PubMed ID: 36808603
[TBL] [Abstract][Full Text] [Related]
11. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
Fuster JJ; Walsh K
Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
Menendez-Gonzalez JB; Rodrigues NP
Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
[TBL] [Abstract][Full Text] [Related]
13. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis and vascular disease.
Amancherla K; Wells JA; Bick AG
Semin Immunopathol; 2022 May; 44(3):303-308. PubMed ID: 35122117
[TBL] [Abstract][Full Text] [Related]
16. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
[TBL] [Abstract][Full Text] [Related]
17. Clonal hematopoiesis, aging, and cardiovascular diseases.
Pardali E; Dimmeler S; Zeiher AM; Rieger MA
Exp Hematol; 2020 Mar; 83():95-104. PubMed ID: 31891750
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis: Pre-cancer PLUS.
Silver AJ; Jaiswal S
Adv Cancer Res; 2019; 141():85-128. PubMed ID: 30691686
[TBL] [Abstract][Full Text] [Related]
19. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC; Wang CY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
[TBL] [Abstract][Full Text] [Related]
20. Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis.
Park E; Evans MA; Doviak H; Horitani K; Ogawa H; Yura Y; Wang Y; Sano S; Walsh K
J Vis Exp; 2021 May; (171):. PubMed ID: 34125083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
